AS

Ali Shilatifard

Northwestern University: 7 patents #180 of 3,846Top 5%
HS Human Genome Sciences: 2 patents #117 of 224Top 55%
OF Oklahoma Medical Research Foundation: 2 patents #57 of 184Top 35%
📍 Chicago, IL: #1,380 of 13,327 inventorsTop 15%
🗺 Illinois: #10,078 of 84,256 inventorsTop 15%
Overall (All Time): #552,338 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11672794 Therapeutic targeting of the BAP1 complex in cancer Lu Wang 2023-06-13
11453640 Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy Kaiwei Liang, Edwin Richard Smith, Gary E. Schiltz, Rama K. Mishra, Kristen Stoltz 2022-09-27
11071727 Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors Zibo Zhao 2021-07-27
11059878 Therapeutic targeting of SET1B/compass pathway for treating cancers Lu Wang 2021-07-13
10640502 Therapeutic targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) in cancers characterized by rearrangements in the mixed lineage leukemia gene (MLL-r) Kaiwei Liang, Edwin Richard Smith, Gary E. Schiltz 2020-05-05
10308698 Therapeutic targeting of SET1B/compass pathway for treating cancers Lu Wang 2019-06-04
10059708 Therapeutic targeting of the interleukin 1 receptor-associated kinase 4 (IRAK4) in leukemias characterized by rearrangements in the mixed lineage leukemia gene (MLL-r) Kaiwei Liang, Edwin Richard Smith 2018-08-28
6379923 ELL2, a new member of an ELL family of RNA polymerase II elongation factors D. Duan, Joan W. Conaway, Ronald Conaway 2002-04-30
6008018 ELL2, a new member of an ELL family of RNA polymerase II elongation factors D. Duan, Joan W. Conaway, Ronald C. Conway 1999-12-28